Biolegend, 515405, Alexa Fluor® 647 anti-human/mouse Granzyme B Antibody, 25tests

Granzyme B is a 32 kD serine protease, also known as granzyme-2, serine protease B, CCP1, Asp-ase, and CTLA-1. Granzyme B is abundantly stored in the granules of cytotoxic T lymphocytes and NK cells. Low level of expression has been reported in granulocytes, B cells, and activated dendritic cells. Granzyme B is crucial for rapid induction of cell death and apoptosis through interaction with mannose-6-phosphate receptor.
25tests
Verified Reactivity: Human, Mouse
Reported Reactivity: Rat
Antibody Type: Monoclonal
Host Species: Mouse
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation: The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 647 under optimal conditions.
Concentration: Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: ICFC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood. * Alexa Fluor® 647 has a maximum emission of 668 nm when it is excited at 633nm / 635nm.Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.View full statement regarding label licenses
Excitation Laser: Red Laser (633 nm)
Application References(PubMed link indicates BioLegend citation): Wever PC, et al. 1998. Immunology. 93:383 Arens R, et al. 2004. J. Exp. Med. 199:1595 Lima M, et al. 2003. Am. J. Pathol. 163:763 Wiede F, et al. 2014. J Autoimmun. 53:105. PubMed Baker GF, et al. 2014. Cancer Res. 74:5079. PubMed Nacer A, et al. 2014. PLoS Pathog. 10:1004528. PubMed Sharma SK, et al. 2015. J Immunol. 194:5529. PubMed
Product Citations: Khan A, et al. 2015. J Virol. 89:3776. PubMed Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed Guo A, et al. 2022. Nature. 607:135. PubMed Jeon Y, et al. 2022. Cancers (Basel). 14:. PubMed Wu Z, et al. 2023. EMBO Rep. 24:e56524. PubMed Oh G, et al. 2023. J Clin Invest. 133:. PubMed Corria-Osorio J, et al. 2023. Nat Immunol. 24:869. PubMed Saxena V, et al. 2022. Cell Rep. 39:110727. PubMed Wang X, et al. 2022. Sci Adv. 8:eabn0071. PubMed Lin YH 2023. Immunity. 56(1):207-223.e8. PubMed Jaiswal A, et al. 2022. Cancer Cell. 40:524. PubMed Donnarumma T, et al. 2016. Cell Rep. 17:1571-1583. PubMed Shimizu K, et al. 2020. Molecular Cell. 77(5):937-950.e6.. PubMed Page N, et al. 2018. Immunity. 48:937. PubMed Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed Farsakoglu Y et al. 2019. Cell reports. 26(9):2307-2315 . PubMed Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed Pachnio A, et al. 2016. PLoS Pathog. 12: 1005832. PubMed Álvaro de Mingo Pulido et al. 2018. Cancer cell. 33(1):60-74 . PubMed Chen M, et al. 2021. Cancers (Basel). 13:. PubMed Liu W, et al. 2021. Cell Mol Immunol. 18:2660. PubMed Davari K, et al. 2021. J Immunother Cancer. 9:. PubMed LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed Wu J, et al. 2020. Sci Adv. 6:eaba3458. PubMed Wiede F, et al. 2021. Cancer Discov. Online ahead of print. PubMed Fumagalli V, et al. 2020. J Exp Med. :217. PubMed Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed Ng W, et al. 2021. Pharm Biol. 59:47:00. PubMed Lin JR et al. 2018. eLife. 7 pii: e31657. PubMed Trotta E, et al. 2018. Nat Med. 24:1005. PubMed Terashima Y, et al. 2020. Nat Commun. 11:609. PubMed Alkasalias T, et al. 2022. Cell Death Discov. 8:464. PubMed Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed Jankeel A, et al. 2020. J Virol. :94. PubMed Ping Y, et al. 2020. Front Cell Dev Biol. 0.890972222. PubMed Jackstadt R, et al. 2019. Cancer Cell. 36:319. PubMed Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed Walk J, et al. 2019. Nat Commun. 10:874. PubMed Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed Schofield DJ, et al. 2021. MAbs. 13:1857100. PubMed Fan Z, et al. 2020. EMBO Mol Med. 12:e11571. PubMed Pais Ferreira D, et al. 2020. Immunity. 53(5):985-1000.e11. PubMed Souza COS, et al. 2021. iScience. 24(6):102548. PubMed Carpentier A, et al. 2017. PLoS One. 10.1371/journal.pone.0181403. PubMed Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed Li J, et al. 2018. Immunity. 49:178. PubMed Zhang T, et al. 2022. Oncogene. . PubMed Pardy RD, et al. 2021. Nat Commun. 12:4051. PubMed Grifoni A, et al. 2020. Cell. 181(7):1489-1501.e15.. PubMed Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed Gordon-Alonso M,et al. 2017. Nat. Commun. 10.1038/s41467-017-00925-6. PubMed Wang B, et al. 2021. J Immunother Cancer. 9:. PubMed Griffin B, et al. 2017. Nat Commun. 10.1038/ncomms15743. PubMed Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed Zhang Y, et al. 2018. Nat Commun. 9:6. PubMed Ambrose AR, et al. 2020. Proc Natl Acad Sci U S A. 117:23717. PubMed Chen H, et al. 2021. iScience. 24:103387. PubMed Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed Ren C, et al. 2022. J Cell Mol Med. 26:1071. PubMed Lou Y, et al. 2021. Int J Mol Sci. 22:. PubMed Hamaidi I, et al. 2020. Cell Metabolism. 32(3):420-436.e12. PubMed Rydyznski Moderbacher C, et al. 2020. Cell. 183(4):996-1012.e19. PubMed Kim J, et al. 2016. Sci Rep. 6:27615. PubMed Khuzwayo S, et al. 2021. Front Immunol. 12:631410. PubMed Fang F, et al. 2021. Cell Rep. 37:109981. PubMed Huang H, et al. 2021. Cell. 184(5):1245-1261.e21. PubMed Iwata TN, et al. 2018. Mol Cancer Ther. 17:1494. PubMed Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed Yao C, et al. 2018. Autophagy. 1.854861111. PubMed Li W, et al. 2020. Immunity. 53(2):456-470. PubMed Chitirala P, et al. 2020. eLife. 9:00. PubMed Srivastava R, et al. 2015. J Immunol. 194:2232. PubMed Pachnio A, et al. 2015. J Immunol. 195: 3803 - 3815. PubMed Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed Dhayade S, et al. 2020. Nutrients. 12:. PubMed Pantelidou C, et al. 2022. NPJ Breast Cancer. 8:102. PubMed Wu R, et al. 2020. J Immunother Cancer. 8:00. PubMed Mackroth M, et al. 2016. PLoS Pathog. 12:e1005909. PubMed Xian S, et al. 2021. EMBO Rep. 22:e52509. PubMed Woods E, et al. 2021. NPJ Vaccines. 6:117. PubMed Lee HN, et al. 2022. JCI Insight. 7:. PubMed Boulch M, et al. 2021. Sci Immunol. 6:. PubMed Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed Coomes S, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.47. PubMed Pflügler S, et al. 2020. Commun Biol. 3:252. PubMed Peng W, et al. 2020. Antimicrob Agents Chemother. 64:. PubMed Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed Mishra GP, et al. 2022. Cell Mol Life Sci. 79:429. PubMed Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
RRID: AB_2294995 (BioLegend Cat. No. 515405) AB_2566333 (BioLegend Cat. No. 515406)
Structure: 32 kD serine protease
Distribution: Cytotoxic T-cells and NK cells, low on granulocytes, B cells and activated dendritic cells
Function: Induction of cell death and apoptosis
Ligand/Receptor: Mannose-6-phosphate receptor
Cell Type: B cells, Dendritic cells, NK cells, T cells
Biology Area: Cell Biology, Immunology, Innate Immunity, Neuroscience
Molecular Family: Enzymes and Regulators, Proteases
Antigen References: 1. Estebanez-Perpina E, et al. 2000. Biol Chem. 381:1203 2. Griffiths GM. And S. Isaaz, et al. 1993. J. Cell Biol. 120:885 3. Spaeny-Dekking EH, et al. 1998. J. Immunol. 160:3610 4. Wagner C, et al. 2008. Mol. Immunol. 45:1761
Gene ID: 300214939171528
UniProt: View information about Granzyme B on UniProt.org
Clone: GB11
Regulatory Status: RUO
Other Names: Granzyme-2, serine protease B, CCP1, Asp-ase, CTLA-1
Isotype: Mouse IgG1, κ